All News

New Rx, new indications, new generics, new OTC

It cuts both ways: You need to manage your manager, just as your manager manages you.

Medication synchronization: Good for patients, good for business, and good for performance metrics.

Three ways to increase income and reach patients in need

Sometimes you just wanna throw the thing at the wall.

AmerisourceBergen amps up its tools for community pharmacies

Mckesson's AccessHealth offers this take on current economic realities

Help patients find solutions to challenges arising from their medical issues, and they'll be back

Community pharmacies competing with preferred pharmacy networks can sharpen their game by focusing on some of the things they do best.

The Ninth Circuit Court has upheld a Washington state law requiring pharmacies to provide patients with all medications in a timely manner.

Letters, e-mails, comments, and posts from Drug Topics readers

There is no shortage of OTC products promising to help maintain healthy hair and scalp, or to repair dry or damaged hair. Check these out, for starters.

In 1974, pharmacists and the pharmacy industry dealt with several important issues.

With Spark Health, pharmacists can track patients' data, monitor their outcomes, and give them plenty of warm fuzzies, 21st-century-style.

Few treatment options are available for irritable bowel syndrome with diarrhea. Eluxadoline acts on the nervous system to lessen bowel contraction.

FDA has issued a warning about a possible link between use of SGLT2 inhibitors and ketoacidosis.

A recent study examined the benefits of extending warfarin therapy for an additional 18 months after an initial six-month treatment period.

CVS Health is crediting its decision to remove tobacco products from its shelves a year ago with a reduction in the numbers of cigarettes sold in some states.

Kmart has sued pharmacy benefits manager (PBM) Catamaran for breach of contract and alleged violations of state and federal laws regarding reimbursements for prescription drug costs.

HIV patients whose antiretroviral therapy was initiated and managed by pharmacists achieved earlier viral suppression compared with those managed by a primary HIV clinician, according a report published in the September 1 issue of the American Journal of Health-System Pharmacy.

Sandoz announced that Zarxio (filgrastim-sndz), the first biosimilar approved by the FDA in March, is now available in the United States.

The state of Illinois will launch a pilot program next year to try to answer that question.

Kmart has agreed to pay $1.4 million to settle charges it used illegal inducements to encourage Medicare patients to forego generics for more expensive brand names.

FDA issued a warning this week that dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes may cause severe and disabling joint pain.

Guest columnist The Cynical Pharmacist offers a proposal every retail pharmacist will love.

More than 7 out of 10 Americans believe that drug costs are unreasonable and drug companies place profits before people, according to a recent Kaiser Health Tracking poll.

Florida’s crackdown on pill mills has resulted in decreases in opioid prescriptions, according to an online study published by JAMA Internal Medicine.

While the rate of new drug shortages has fallen, manufacturing problems and FDA import bans continue to cause shortages of certain medications in U.S. hospitals.